Pfizer: the readout is dated and the optionality is free
The trial reads out on a known date and the current price ascribes almost nothing to it. The asymmetry is the position, not the probability.
Evidence · 5 cards
Discussion · 3
This changed my mind. The channel data is what makes this hard to dismiss. What would you need to see to add rather than hold?
I came in sceptical. The elasticity decay across the price actions is the tell. How much of this do you think is already in the buy side's numbers?
Fair challenge. Invalidation is a close below the lock price on volume, and I should have written that into the card rather than leaving it implicit. (923)